Day Trader తెలుగు
13:43 · Nov 10, 2022 · Thu
NATCO PHARMA: Q2 EBITDA 953M RUPEES VS 705M (YOY) || Q2 EBITDA MARGIN 22.06% VS 18.69% (YOY)
BEAT EBITDA AND MARGINS
Please enable JavaScript to view the
comments powered by Disqus.
Home